glp-1 market Receptor Agonist Size, Share GLP-1 Agonists Market Report 2025-2033,
Description
In contrast, GLP-1 injections typically produce 15-25% weight loss in clinical trials
Pancreatitis, pancreatic, and thyroid cancer with GLP-1-based therapies
Patients taking levothyroxine benefit from dual therapy because it provides more consistent weight loss momentum while maintaining stable thyroid function
Others may feel unsure about mild side effects and consider stopping treatment too soon
[DOI] [PMC free article] [PubMed] [Google Scholar] 202.Chen Y, Li Z, Yang Q, et al
Jones DW, Ferdinand KC, Taler SJ, et al
